The company aims to implant chips in people's brains to enable disabled individuals to control computers with their minds, ultimately unlocking human potential. Neuralink's mission is to "create a generalized brain interface to restore autonomy to those with unmet medical needs today and unlock human potential tomorrow."
The company believes that brain-computer interfaces have the potential to change lives for the better. "We are currently focused on giving people with quadriplegia the ability to control their computers and mobile devices with their thoughts," Neuralink notes. "In the future, we hope to restore capabilities such as vision, motor function, and speech, and eventually expand how we experience the world."
WATCH: JOHN LEGEND CALLS TRUMP A RACIST
May 26, 2023
The implant is fully implantable, cosmetically invisible, and designed to allow users to control a computer or mobile device anywhere they go. The N1 Implant is powered by a small battery charged wirelessly from the outside via a compact, inductive charger that enables easy use from anywhere.
WATCH FETTERMAN REACTING TO PROTESTS WAVES
The company has not yet opened recruitment for its clinical trial but will announce more information soon. The approval from the FDA represents an essential first step for Neuralink, which has been working closely with the FDA to achieve this milestone. Elon Musk congratulated the Neuralink team on Twitter, expressing his excitement for the company's future. With this approval, Neuralink is one step closer to realizing its vision of unlocking human potential through brain-computer interfaces.
Discover alternative ideas that will make you think
Engage in mind bending debate
Earn points, rise in rank, have fun
